Notably, severe AMPK-activating PRKAG2 mutations such as the R531Q variant result in fatal neonatal cardiomyopathy with prenatal bradycardia and extreme cardiomegaly [46], mirroring the perinatal lethality and cardiac dysfunction observed in our Pkm1-KO mice. This evidence concerns the gene PRKAG2 and cardiomyopathy.